Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Rallybio Corp (RLYB)

Rallybio postpones Avenzo merger closing, delays cash distribution timing

Negative Impact 4 of 5 m&a

Rallybio said the closing of its merger with Avenzo Therapeutics, previously expected on November 6, 2026, has been postponed because certain conditions tied to listing the company's shares after the deal have not been met. The company did not deposit funds for a previously announced cash distribution with Computershare on November 5, 2026, so the payment and ex-dividend dates may be delayed.

Key points

  • Merger closing with Avenzo Therapeutics postponed from the expected November 6, 2026 date while listing approvals are sought
  • Funds for the cash distribution were not deposited with Computershare on November 5, 2026
  • Previously announced payment date and ex-dividend date for the cash distribution may be delayed; no new dates given

The filing

CompanyRallybio Corp (RLYB)
Form8-K, current report
Filed with the SECNov 6, 2026, 5:26 PM ET
Accession number0001193125-26-452115

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 7:05 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.